Asthma affects over 260 million people worldwide, and inhalers remain the cornerstone of effective asthma management. Whether you’ve been newly diagnosed or are revisiting your treatment plan, understanding the full landscape of available inhalers — their names, types, and purposes — can help you have more informed conversations with your doctor and take better control of your breathing.
This guide covers the complete list of asthma inhaler names across every major category, from quick-relief rescuers to long-term controllers.
Why Inhalers Are the Gold Standard for Asthma
Inhalers deliver medication directly to the airways, which means faster action and fewer systemic side effects compared to oral medications. The two core goals of asthma treatment are:
- Relieving acute symptoms (bronchospasm, wheezing, breathlessness)
- Controlling long-term inflammation to prevent attacks
Different inhalers serve different roles, and many people with moderate-to-severe asthma use more than one type. Understanding which inhaler does what is the first step toward an effective asthma action plan.
Category 1: Short-Acting Beta-Agonists (SABAs) — Rescue Inhalers
SABAs are the “rescue inhalers” most people associate with asthma. They work rapidly — within minutes — to relax the muscles around the airways during an acute asthma attack or episode of breathlessness.
Common SABA Inhaler Names
| Generic Name | Brand Names |
|---|---|
| Salbutamol (Albuterol) | Ventolin, ProAir HFA, Proventil HFA, AccuNeb, Salamol |
| Levalbuterol | Xopenex, Xopenex HFA |
| Terbutaline | Bricanyl, Terbulin |
| Pirbuterol | Maxair (discontinued in many markets) |
| Fenoterol | Berotec |
Ventolin (salbutamol/albuterol) is by far the most widely prescribed rescue inhaler globally. It begins working within 3–5 minutes and its effects last 4–6 hours. It is suitable for adults and children alike and is the standard first-line rescue therapy in most asthma guidelines.
Levalbuterol (Xopenex) is the purified R-isomer of albuterol, marketed as producing fewer side effects such as tremor or rapid heartbeat. It is often used in patients who experience notable side effects from standard albuterol.
Important: Rescue inhalers should not be used more than twice a week for symptom relief. Frequent use signals that asthma is not adequately controlled, and a doctor should be consulted about stepping up therapy.
Category 2: Long-Acting Beta-Agonists (LABAs)
LABAs are not used alone for asthma — they are always combined with an inhaled corticosteroid (ICS). They relax the airway smooth muscle for 12 hours or more, providing sustained bronchodilation.
Common LABA Inhaler Names
| Generic Name | Brand Names |
|---|---|
| Salmeterol | Serevent Diskus |
| Formoterol | Foradil Aerolizer, Oxeze, Performist |
| Indacaterol | Onbrez (more common in COPD) |
| Vilanterol | Used in combination products only |
| Olodaterol | Striverdi Respimat (more common in COPD) |
Salmeterol (Serevent) was one of the first LABAs approved for asthma and is taken twice daily. It is always prescribed alongside an ICS and is never used as a standalone rescue medication.
Formoterol (Foradil, Oxeze) has the added benefit of a relatively faster onset, making it suitable for use in combination products that double as maintenance-and-reliever therapy (MART).
Category 3: Inhaled Corticosteroids (ICS) — The Controllers
Inhaled corticosteroids are the most important long-term controller medications for persistent asthma. They reduce airway inflammation, decrease mucus production, and lower the frequency and severity of asthma attacks. They do not provide immediate symptom relief.
Common ICS Inhaler Names
| Generic Name | Brand Names |
|---|---|
| Beclomethasone | Qvar, Beclovent, Clenil, Beclate |
| Budesonide | Pulmicort, Pulmicort Flexhaler, Pulmicort Respules |
| Fluticasone propionate | Flovent HFA, Flovent Diskus, Flixotide |
| Fluticasone furoate | Arnuity Ellipta |
| Ciclesonide | Alvesco |
| Mometasone | Asmanex Twisthaler, Asmanex HFA |
| Triamcinolone | Azmacort (discontinued in the US) |
| Flunisolide | AeroBid (discontinued in some markets) |
Budesonide (Pulmicort) is one of the most studied ICS agents and is approved for use in children as young as 1 year through the nebuliser form (Pulmicort Respules). The Flexhaler version is a dry powder inhaler suitable for older children and adults.
Fluticasone propionate (Flovent) is widely prescribed and comes in both metered-dose inhaler (HFA) and dry powder inhaler (Diskus) formulations, giving patients options based on their inhalation technique and preference.
Ciclesonide (Alvesco) is activated only in the lungs, which means fewer oral side effects, such as thrush (oral candidiasis), compared with some other ICS agents.
Category 4: ICS/LABA Combination Inhalers
These combination inhalers pair an inhaled corticosteroid with a long-acting beta-agonist in a single device. They simplify treatment regimens and are the most commonly prescribed maintenance therapy for moderate-to-severe asthma.
Common ICS/LABA Combination Inhaler Names
| Generic Names | Brand Names | Device Type |
|---|---|---|
| Fluticasone/Salmeterol | Advair Diskus, Advair HFA, Seretide | Diskus / MDI |
| Budesonide/Formoterol | Symbicort, Duoresp Spiromax | Turbuhaler / MDI |
| Fluticasone furoate/Vilanterol | Breo Ellipta | Dry powder |
| Mometasone/Formoterol | Dulera, Zenhale | MDI |
| Beclomethasone/Formoterol | Foster, Fostair | MDI |
| Fluticasone/Formoterol | Flutiform | MDI |
Advair/Seretide (fluticasone/salmeterol) is one of the most-prescribed combination inhalers in the world. It is available in multiple strengths and two device types, allowing physicians to tailor the dose to the patient’s severity.
Symbicort (budesonide/formoterol) is notable because formoterol has a faster onset than salmeterol, making Symbicort suitable for MART (Maintenance And Reliever Therapy) — a regimen in which the same inhaler is used for both daily maintenance and as-needed symptom relief.
Breo Ellipta (fluticasone furoate/vilanterol) is a once-daily combination inhaler, which may improve adherence among patients who find twice-daily dosing difficult to maintain consistently.
Category 5: Long-Acting Muscarinic Antagonists (LAMAs)
LAMAs are primarily used in COPD but are increasingly prescribed as add-on therapy for uncontrolled asthma, particularly in adult patients. They work by blocking muscarinic receptors, preventing bronchoconstriction through a different pathway than beta-agonists.
Common LAMA Inhaler Names for Asthma
| Generic Name | Brand Names |
|---|---|
| Tiotropium | Spiriva Respimat |
| Umeclidinium | Incruse Ellipta (primarily COPD) |
Tiotropium (Spiriva Respimat) has been approved as an add-on therapy for adults with symptomatic asthma despite ICS/LABA treatment. Studies have shown it can help reduce exacerbations and improve lung function in this group.
Category 6: ICS/LABA/LAMA Triple Combination Inhalers
For patients with severe asthma (or overlapping COPD), triple therapy in a single inhaler simplifies regimens and may improve outcomes.
| Generic Names | Brand Names |
|---|---|
| Fluticasone furoate/Umeclidinium/Vilanterol | Trelegy Ellipta |
| Budesonide/Glycopyrrolate/Formoterol | Breztri Aerosphere |
These are primarily used in COPD but may be prescribed off-label or in asthma-COPD overlap syndrome (ACOS).
Category 7: Short-Acting Muscarinic Antagonists (SAMAs)
SAMAs such as ipratropium are occasionally used in acute asthma exacerbations, particularly in emergency settings, alongside SABAs to provide additional bronchodilation.
| Generic Name | Brand Names |
|---|---|
| Ipratropium bromide | Atrovent HFA, Ipravent |
Combination SABA/SAMA:
| Generic Names | Brand Names |
|---|---|
| Albuterol/Ipratropium | Combivent Respimat, DuoNeb |
Category 8: Leukotriene Receptor Antagonists (LTRAs) — Oral, Not Inhaled
While not inhalers, LTRAs such as Montelukast (Singulair) and Zafirlukast (Accolate) are often used alongside inhaler therapy and are worth mentioning in a comprehensive asthma management overview. They block inflammatory chemicals that narrow the airways and are often used in mild persistent asthma or as add-on therapy.
Choosing the Right Inhaler Device
The medication inside an inhaler matters, but so does the device that delivers it. The main types of inhaler devices are:
- Metered-Dose Inhaler (MDI): Pressurised canister; requires good coordination. Often used with a spacer.
- Dry Powder Inhaler (DPI): Breath-activated; no propellants; easier coordination but requires a strong inhalation.
- Soft Mist Inhaler (SMI): Slower-moving mist; good for those with poor coordination (e.g., Respimat).
- Nebuliser: Converts liquid medication to a fine mist; used for severe attacks or young children.
Tips for Effective Inhaler Use
- Always use a spacer with an MDI — studies show spacers significantly improve medication delivery to the lungs.
- Rinse your mouth after using an ICS to reduce the risk of oral thrush.
- Keep a rescue inhaler with you at all times — at home, at work, and in your bag.
- Review your technique regularly with a pharmacist or nurse — incorrect technique is one of the most common reasons asthma remains uncontrolled.
- Check expiry dates and device fullness regularly; many patients continue using empty or near-empty inhalers.
Final Thoughts
Asthma management is not one-size-fits-all. The right inhaler — or combination of inhalers — depends on your asthma severity, age, ability to use the device correctly, frequency of symptoms, and any coexisting conditions.
This complete list of asthma inhaler names is a reference guide, not a prescription. Always work with your doctor or respiratory specialist to find the regimen that works for your specific lungs. With the right inhaler in hand and the right technique for using it, life with asthma can be well-managed and full.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
